Private Capital Group’s Integra LifeSciences IART Stock Holding History

Private Capital Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$7K	Hold	120	–	–	0.01%	1147
2022 Q1	$8K	Sell	120 -7	-6%	-$461	﹤0.01%	1349
2021 Q4	$9K	Hold	127	–	–	﹤0.01%	1334
2021 Q3	$9K	Hold	127	–	–	﹤0.01%	1371
2021 Q2	$9K	Sell	127 -13	-9%	-$919	﹤0.01%	1366
2021 Q1	$10K	Sell	140 -743	-84%	-$50.3K	﹤0.01%	1288
2020 Q4	$57K	Buy	883 +208	+31%	+$11.2K	0.01%	718
2020 Q3	$32K	Sell	675 -61	-8%	-$2.9K	0.01%	905
2020 Q2	$35K	Buy	736 +46	+7%	+$2.26K	0.01%	871
2020 Q1	$31K	Buy	690 +76	+12%	+$3.99K	0.01%	834
2019 Q4	$35K	Hold	614	–	–	0.01%	883
2019 Q3	$37K	Buy	614 +300	+96%	+$17.9K	0.01%	907
2019 Q2	$20K	Sell	314 -303	-49%	-$15.6K	﹤0.01%	1082
2019 Q1	$34K	Buy	617 +87	+16%	+$4.43K	0.01%	950
2018 Q4	$24K	Buy	530 +216	+69%	+$11.9K	0.01%	1011
2018 Q3	$20K	Hold	314	–	–	﹤0.01%	1144
2018 Q2	$20K	Sell	314 -353	-53%	-$21.9K	﹤0.01%	1111
2018 Q1	$37K	Sell	667 -4	-0.6%	-$210	0.01%	817
2017 Q4	$32K	Buy	+671	New	+$32.8K	0.01%	869

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Private Capital Group's IART Position: Q2 2022 in Review

Private Capital Group held its Integra LifeSciences (IART) position steady in Q2 2022 at 120 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #1147.

Private Capital Group first reported a position in IART in Q4 2017 and has held it in 19 quarters since. The position peaked at $57K in Q4 2020. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Private Capital Group held 120 shares of Integra LifeSciences worth $7K as of Q2 2022.
Private Capital Group left its Integra LifeSciences share count unchanged in Q2 2022.
Integra LifeSciences made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1147 holding.
Private Capital Group first reported a position in Integra LifeSciences in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Integra LifeSciences position peaked at $57K in Q4 2020.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.